• Home
  • Training
    • View Courses
  • careers
    • Sales Executive (Contract)
  • Tender
  • Registration
    • #VisitRupavahini Permission Request 
    • Rupavahini The Acting Academy 
    • Nugasewana Resource Personnel Registration
    • Dengue GO!
    • SL Industry
    • Nena Mihira
    • Guwan Sihinaya
  • About
  • Contact
NIA arrests absconding accused in Sri Lankan human trafficking case
October 23, 2023
Triple threat of diarrhea, respiratory and eye diseases
October 23, 2023
Published by on October 23, 2023
Categories
  • Uncategorized
Tags

A pill for dengue fever developed by Johnson & Johnson (JNJ.N) appeared to protect against a form of the virus in a handful of patients in a small human challenge trial in the United States, according to data presented by the company.

Share
0

Related posts

October 25, 2023

New Health Minister vows to make crucial changes


Read more
October 24, 2023

Special programme underway to provide visas


Read more
October 24, 2023

Fallen trees cause traffic standstill on Ella-Wellawaya road


Read more

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

P.O. Box 2204,
Independance Square,
Colombo – 07.

Useful Links

Home
Media Channel
Annual Reports
Contact
Trainings
Tenders

Follow us on social media!

Sri Lanka Rupavahini (TV) Corporation © 2023. Powered By OLAK
Rupavahini
Nethra TV
Channel Eye